Letter

Treating major depression in children and adolescents

BMJ 2004; 328 doi: 10.1136/bmj.328.7438.524-b (Published 26 February 2004)
Cite this as: BMJ 2004;328:524.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Research is needed into safer and more effective drugs

  1. Macey L Murray, research fellow (macey.murray@ulsop.ac.uk),
  2. Ian C K Wong, director,
  3. Corinne S de Vries, senior lecturer
  1. Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London, London WC1N 1AX
  2. Department of Pharmacoepidemiology, Postgraduate Medical School, University of Surrey, Guildford GU2 7DJ

    EDITOR—We report our preliminary findings on prescribing of antidepressants in general practice, in response to the recommendation by the regulatory agency for medicines and healthcare products to withdraw selective serotonin reuptake inhibitors from use in paediatric depression.1 2

    We used the general practice research database to analyse use between 1 January 1992 and 31 December 2001 (88 522 prescriptions issued to 23 999 …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular